Related Experiment Videos

Treatment of schizophrenia with a vasopressin analogue

A C Iager, D G Kirch, L B Bigelow

The American Journal of Psychiatry

|March 1, 1986

Abstract:

Ten patients with chronic schizophrenia completed a 3-month double-blind, placebo-controlled trial with a vasopressin analogue. Modest improvement occurred, but several patients also experienced significant fluid and electrolyte imbalance.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Relative risk of neurological signs in siblings of patients with schizophrenia.

The American journal of psychiatry·2001

A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis.

Brain research bulletin·2001

Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: a preliminary study.

Psychiatry research·2001

Differential and region-specific activation of mitogen-activated protein kinases following chronic administration of phencyclidine in rat brain.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2001

Measuring contributions to the clinical mission of medical schools and teaching hospitals.

Academic medicine : journal of the Association of American Medical Colleges·2000

Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.

Archives of general psychiatry·2000

See all related articles